Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Lotuzol is a new herbal drug composing water extract powder of Nelumbinis Semen to treat depression without sexual dysfunction, a major adverse effect in commonly used anti-depressants. More
A series of SynLeptin peptides, particularly, SynLeptin-2 shows remarkable anti-obesity activities which were verified in animal experiments using mice and rabbits. More
A digital topography imaging system that allows for quality three dimensional topographic reconstruction of single crystals. More
Related Reports
Market Research Reports provided by reports.innovaro.com
Jan 2006 - 18 pages - $1,400
Nov 2010 - 16 pages - $99
Oct 2010 - 11 pages - $99
Mar 2008 - 12 pages - $1,100
Feb 2011 - 14 pages - $99
Dec 2010 - 15 pages - $99
Sep 2010 - 20 pages - $99
Jan 2010 - 26 pages - $99
Jul 2011 - 7 pages - $1,895
Oct 2010 - 22 pages - $99
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us